开盘$17.77
昨收$18.06
当日区间$17.22 – $18.05
成交量3.93M
市值$1.97B
市盈率（TTM）–
股息率4.62%
OLN 相关新闻
匹配 Olin 或代码 OLN 的头条新闻，按最新排序。
- Goldman Sachs Maintains Olin(OLN.US) With Hold Rating, Cuts Target Price to $18 负面
- Citi Maintains Olin(OLN.US) With Hold Rating, Cuts Target Price to $17 负面
- Mizuho Securities Maintains Olin(OLN.US) With Hold Rating, Cuts Target Price to $21 负面
- Citi Maintains Olin(OLN.US) With Hold Rating, Cuts Target Price to $19 负面
- J.P. Morgan Maintains Olin(OLN.US) With Hold Rating, Cuts Target Price to $19 负面
- Goldman Sachs Maintains Olin(OLN.US) With Hold Rating, Cuts Target Price to $20 负面
- Wells Fargo Downgrades Olin(OLN.US) to Hold Rating, Cuts Target Price to $20 负面
- RBC Capital Maintains Olin(OLN.US) With Hold Rating, Cuts Target Price to $20 负面
- BofA Securities Downgrades Olin(OLN.US) to Sell Rating 负面
- Truist Financial Maintains Olin(OLN.US) With Hold Rating, Cuts Target Price to $20 负面
- UBS Maintains Olin(OLN.US) With Hold Rating, Cuts Target Price to $21 负面
- Olin | 8-K: Current report
- Deutsche Bank Maintains Olin(OLN.US) With Hold Rating, Cuts Target Price to $20 负面
- Olin | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
- Chengdu Olymvax Biopharmaceuticals Inc: Annual Report Summary 2025 of Chengdu Olin Bio-Tech Co., Ltd.
暂无评论——快来第一个聊聊 OLN。
登录后参与讨论。